| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1849 | 2020 |
| COVID-19 and cancer: lessons from a pooled meta-analysis A Desai, S Sachdeva, T Parekh, R Desai JCO global oncology 6, 2020 | 367 | 2020 |
| Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ... Annals of oncology 32 (6), 787-800, 2021 | 292 | 2021 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 173 | 2021 |
| COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials A Desai, JF Gainor, A Hegde, AM Schram, G Curigliano, S Pal, SV Liu, ... Nature reviews Clinical oncology 18 (5), 313-319, 2021 | 153 | 2021 |
| Financial toxicity of cancer treatment: moving the discussion from acknowledgement of the problem to identifying solutions A Desai, B Gyawali EClinicalMedicine 20, 2020 | 143 | 2020 |
| Mortality in hospitalized patients with cancer and coronavirus disease 2019: a systematic review and meta‐analysis of cohort studies A Desai, R Gupta, S Advani, L Ouellette, NM Kuderer, GH Lyman, A Li Cancer 127 (9), 1459-1468, 2021 | 126 | 2021 |
| Crowdsourcing a crisis response for COVID-19 in oncology A Desai, J Warner, N Kuderer, M Thompson, C Painter, G Lyman, ... Nature cancer 1 (5), 473-476, 2020 | 93 | 2020 |
| Takotsubo cardiomyopathy in cancer patients A Desai, A Noor, S Joshi, AS Kim Cardio-oncology 5, 1-16, 2019 | 70 | 2019 |
| COVID-19 and cancer: a review of the registry-based pandemic response A Desai, TJ Mohammed, N Duma, MC Garassino, LK Hicks, NM Kuderer, ... JAMA oncology 7 (12), 1882-1890, 2021 | 59 | 2021 |
| COVID-19 and Cancer Consortium NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study …, 2020 | 58 | 2020 |
| Drugging KRAS: current perspectives and state-of-art review K Parikh, G Banna, SV Liu, A Friedlaender, A Desai, V Subbiah, A Addeo Journal of hematology & oncology 15 (1), 152, 2022 | 55 | 2022 |
| Racial disparities in COVID-19 outcomes among black and white patients with cancer J Fu, SA Reid, B French, C Hennessy, C Hwang, NT Gatson, N Duma, ... JAMA network open 5 (3), e224304-e224304, 2022 | 47 | 2022 |
| Mitigating acute chemotherapy-associated adverse events in patients with cancer NM Kuderer, A Desai, MB Lustberg, GH Lyman Nature Reviews Clinical Oncology 19 (11), 681-697, 2022 | 44 | 2022 |
| Antibody-drug conjugates: A promising novel therapeutic approach in lung cancer A Desai, P Abdayem, AA Adjei, D Planchard Lung Cancer 163, 96-106, 2022 | 44 | 2022 |
| Smoldering mantle cell lymphoma H Ye, A Desai, D Zeng, K Nomie, J Romaguera, M Ahmed, ML Wang Journal of Experimental & Clinical Cancer Research 36, 1-10, 2017 | 43 | 2017 |
| Association between androgen deprivation therapy and mortality among patients with prostate cancer and COVID-19 AL Schmidt, MD Tucker, Z Bakouny, C Labaki, CY Hsu, Y Shyr, ... JAMA network open 4 (11), e2134330-e2134330, 2021 | 40 | 2021 |
| Submucosal tunneling endoscopic resection of upper gastrointestinal tract tumors arising from muscularis propria D Jain, A Desai, E Mahmood, S Singhal Annals of Gastroenterology 30 (3), 262, 2017 | 40 | 2017 |
| Tissue-agnostic activity of BRAF plus MEK inhibitor in BRAF V600–mutant tumors JJ Adashek, AK Menta, NK Reddy, AP Desai, J Roszik, V Subbiah Molecular cancer therapeutics 21 (6), 871-878, 2022 | 36 | 2022 |
| Endpoints used in phase III randomized controlled trials of treatment options for COVID-19 A Desai, B Gyawali EClinicalMedicine 23, 2020 | 36 | 2020 |
Makhdum Ahmed, MD, PhDAstraZeneca Hematology Oncology在 astrazeneca.com 的电子邮件经过验证
